Source: University of Waikato
A University of Waikato researcher is working on a type of Vitamin K that could reduce the mortality rate among Covid-19 patients.
Dr Aydin Berenjian is a key member of the University’s Chemical and Biological Engineering team and a world renowned expert in menaquinone-7, a type of vitamin. He has been working in collaboration with Penn State University, in Pennsylvania, since 2014 to develop a new technology to produce the vitamin for commercial use.
Menaquinone-7 is already known to aid in the prevention of osteoporosis and cardiovascular disease and now there is evidence that it may be effective in helping people with Covid-19 recovery.